Inotiv delays FY2022 results; preliminary revenue $547.7M; NHP import probe ongoing

Inotiv, Inc.

Preliminary FY2022 revenue ~$547.7M (up from $89.6M in FY2021); DSA backlog $147.2M.
Delay due to criminal probe and subpoenas regarding Cambodian NHP imports; company cooperating.
Voluntarily halted US sales of Cambodian NHPs; ~$140M of FY2022 revenue from those imports.
May need to request credit covenant waiver/amendment; filing Form 12b-25 for 10-K extension.
Three potential scenarios: resumption of sales/imports, sales only, or neither; no timeframe.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Inotiv, Inc. reported the fiscal year ended September 30, 2022 results: revenue approximately $547.7 million.

Period: the fiscal year ended September 30, 2022
Revenue: approximately $547.7 million
Result: preliminary results

Exact text from the filing

Total revenue for FY 2022 is expected to increase to approximately $547.7 million from total revenue of $89.6 million in FY 2021.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Inotiv, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-126069

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.